Spans the full spectrum, encompassing counseling clients through antitrust issues that affect business relationships, including joint ventures and competitor collaborations, shepherding transactions through the merger review process, and litigating antitrust cases, including criminal matters.
Bankruptcy & Restructuring:
Represents all parties and interests involved in the debtor/ creditor relationship in Chapter 11 cases and out-of-court restructurings as well as buyers in bankruptcy sales and other insolvency proceedings. Their national practice representing tax-exempt bondholders and their indenture trustees is considered to be one of the premier bankruptcy and workout practices for tax-exempt securities holders nationwide.
Advises and represents clients in a broad range of regulatory, legislative, and litigation matters before the FCC, Congress, state public utility commissions, Executive Branch agencies, and federal and state courts, as well as on domestic and international business transactions.
Corporate & Securities:
Advises clients internationally, from start-ups with little more than an idea to large multinational companies, venture capital firms and investment banks, and research organizations and institutions, in all stages of the capitalraising process (from start-up funding, to initial public offerings, to continuing debt and equity finance needs, including private placements and public offerings), as well as on corporate governance and compliance, licensing and collaborations, and mergers and acquisitions.
Employment, Labor & Benefits:
Advises employers on complex employment issues, including federal, state and local labor, employment and benefits-related compliance; defending wage and hour, discrimination, and retaliation claims, including class and collective actions; litigating and advising on non-compete and trade secret matters; handling collective bargaining agreements and other labor issues; and counseling on HR policies and practices, including benefit and executive compensation plans and the Affordable Care Act.
Mintz Levin was one of the first law firms to establish a dedicated clean technology practice, which later expanded to also include full-service representation of companies advancing technology innovations used in established energy sectors. The group works with start-ups to established companies and financing sources, and is one of the only law firms that counts its Energy Technology Practice among its top industry practices. The practice serves more than 300 clients, and since 2006 has completed more than 400 transactions in this sector totaling over $7 billion.
Represents the nation’s most sophisticated corporations in high-profile environmental matters, including the prosecution and defense of complex claims under federal and state environmental laws, the permitting of major energy and infrastructure projects, and the remediation and redevelopment of Brownfields.
Represents public, private and nonprofit health care providers and suppliers, payors, investors, pharmaceutical, biotech, and medical device companies in all stages of commercial development. Attorneys provide a variety of transactional litigation, and regulatory services and advise clients on issues involving accreditation, licensing, and certification; antitrust; clinical trials and FDA regulations; corporate governance; fraud and abuse; health care compliance, reimbursement and other regulatory matters; HIPAA and other laws governing health information privacy and security; and government investigations.
Focus on protecting, licensing and enforcing patents, trademarks, trade secrets and other IP. Approach informed by understanding clients’ industries and appreciation of the strategic advantage a creative and forward-looking portfolio strategy provides. Represent clients before the USPTO, District Courts, International Trade Commission, and other regulatory and administrative agencies and tribunals.
Mintz Levin has served as one of the leading law firms to the life sciences industry since the industry’s birth in the 1970s. Today, the firm advises life science companies of every size, from start-ups looking for their first funding to public companies with products on the market, as well as venture capital firms, investment banks, research and academic institutions, and others engaged in the life sciences ecosystem.
Focus on antitrust, bankruptcy, construction, corporate compliance and internal investigations, employment, environmental, Foreign Corrupt Practices Act, insurance and reinsurance, intellectual property, product liability and complex tort litigation, securities, white collar defense, and real estate and land use. Clients include closely held corporations, Fortune 100 companies, and multinational corporations, including businesses in the financial services, technology, construction, health care, and life sciences industries.
Represent issuers, conduit borrowers, underwriters, credit enhancers, and other market participants in tax-exempt bond financings in public and private placements. Advise buyers and holders of tax-exempt bonds and their trustees and market participants on related matters, such as synthetic or derivative financial products, post-issuance compliance with tax and securities laws, legislative drafting and monitoring, and general financing. In addition, the firm has a nationally pre-eminent practice representing bondholders and their trustees in maximizing capital recovery on defaulted transactions.
Represent owners, developers, public and private agencies, lenders, tenants, and landlords across the country in sophisticated real estate acquisitions, dispositions, developments, financings, and leasing transactions. The real estate practice also advises corporations with facilities around the world.